Forty-three Pseudomonas cepacia isolates were screened for the production of pyochelin. Twenty-one (49%) produced pyochelin, and 22 (51%) were pyochelin negative. Of the 21 strains producing pyochelin, 18 were from patients with severe infections, 11 of which resulted in death. Of the 22 strains which did not produce pyochelin, 13 were from patients with mild or moderate infections. Pyochelin production by P. cepacia isolates infecting cystic fibrosis patients correlates with morbidity and mortality in these patients. Pyochelin was shown to stimulate the in vitro growth of P. cepacia in the presence of transferrin. P. cepacia isolates were able to accumulate 59Fe-pyochelin regardless of whether they produced this siderophore.
Cystic fibrosis (CF) patients are particularly at risk for pulmonary colonization and infection. Pseudomonas aeruginosa has been the pathogen of primary concern in CF patients, since 70 to 80% of CF patients have chronic respiratory tract colonization with P. aeruginosa (5) . In the past, other Pseudomonas species have been much less frequently isolated from CF patients (5) . However, in a recent study characterizing microorganisms isolated from sputum cultures of CF patients at the Toronto Sick Children's Hospital CF clinic, it was found that the isolation rate for P. cepacia had increased from 10% in the period from 1970 to 1977 to 18% in 1981 (5) . In a similar study at the CF center of St. Christopher's Hospital for Children in Philadelphia, Pa., it was reported that 20% of 425 CF patients were colonized with P. cepacia (P. H. Gilligan and D. V. Schidlow, Clin. Microbial. Newsl. 6:42-44, 1984) . Both studies reported a correlation between the isolation of P. cepacia from the respiratory tract and a deterioration in clinical status (5; Gilligan and Schidlow, Clin. Microbiol. Newsl. 6:42-44, 1984) . Several patients developed fulminant pneumonia, recurrent fever, elevated leukocyte counts, weight loss, and a relentless, often fatal, deterioration in pulmonary function (5) .
Little is known about the mechanisms of pathogenicity of P. cepacia. P. cepacia isolates from CF patients have been reported to produce protease and lipase (6) and flagella (8) , but none of these products have been shown to correlate with the virulence of P. cepacia. The CF isolates examined produced no cytotoxins (6) .
The ability to acquire iron has been correlated with the ability of a variety of bacteria to establish and maintain infections (10) . The present study was undertaken to determine the possible relationship between pathogenicity and siderophore production in P. cepacia. In a previous study (11) , some strains of P. cepacia were shown to produce the siderophore pyochelin. Therefore, in this study, the ability of P. cepacia isolates to produce and utilize pyochelin was examined.
MATERIALS AND METHODS Strains. P. cepacia isolates from the sputa of CF patients and patient correlations were generously supplied by C. L. Prober, the Hospital for Sick Children, Toronto, Ontario, and J. D. Klinger, Rainbow Babies' and Children's Hospital, Cleveland, Ohio. P. aeruginosa PAO has previously been described by Holloway et al. (4) .
Culture conditions. For detection of pyochelin, cultures were grown in 50 ml of 0.5% Casamino Acids (Difco Laboratories, Detroit, Mich.), which was deferrated with Chelex-100 (Bio-Rad Laboratories, Richmond, Calif.). Chelex-100 was added to a concentration of 5 g/liter and stirred at room temperature for 5 h. Chelex-100 was removed by filtration through Whatman, Inc. (Clifton, N.J.), no. 4 filter paper. The pH was adjusted to 7.4, and MgCl2 was added to a concentration of 0.4 mM prior to autoclaving (CAA medium). For pyochelin production, cultures were grown for 24 h at 30°C with maximum aeration. All glassware was acid washed and rinsed with deionized H20. All reagents and media were prepared with H20 purified by the Milli-Q system (Millipore Corp., Bedford, Mass.).
Growth promotion assays were conducted in M9 minimal medium supplemented with 0.5% glucose (13), 10 mM sodium bicarbonate, and 100 ,ug of transferrin per ml (Sigma Chemical Co., St. Louis, Mo.) (transferrin medium).
Purification of pyochelin. Supernatants from cultures grown in CAA medium were adjusted to pH 2.0, extracted with ethyl acetate (2 volumes of ethyl acetate:5 volumes of supernatant), and concentrated by rotary evaporation. The residues were dissolved in methanol and chromatographed on a thin layer (250 ,um) of Silica Gel G with chloroformacetic acid-ethanol (90:5:2.5) as the development solvent. The fluorescent spots containing pyochelin were scraped from the plate. Pyochelin was eluted from the silica gel by extraction twice with methanol. The methanol extracts were concentrated by rotary evaporation and chromatographed on a second thin-layer plate in a 90:5:5 ratio of the same solvents. Pyochelin was eluted from the gel in methanol. The methanol extracts were put into preweighed vials, dried under vacuum, and stored at room temperature in the dark (1) .
Assay for pyochelin production. P. cepacia isolates were grown in 50 ml of CAA medium. The supernatants were extracted with ethyl acetate and chromatographed in the first thin-layer silica gel. Pyochelin was detected by yellow-green fluorescence under UV light and a red-brown reaction when sprayed with 0.1 M FeCl3 in 0.1 M HCl. Pyochelin, purified as described above, was chromatographed for comparison with the P. cepacia extracts. Spectroscopic procedures. Absorption spectra for purified pyochelin in the visible and UV ranges were obtained with a model 80 Pye-Unicam spectrophotometer.
Growth assays. P. cepacia isolates were grown in M9-glucose medium supplemented with 200 ,ug of the iron chelator ethylenediamine-N,N'-diacetic acid per ml for 24 h at 30°C. These cultures were adjusted to a concentration of 10' CFU/ml in transferrin medium. Pyochelin dissolved in ethanol was added to cultures at a final concentration of 10 jig/ml. Equivalent amounts of ethanol were added to control cultures. Cultures were incubated at 300C. Growth was monitored by measuring the increase in A6N with time.
Growth was also measured by determining viable counts on Trpticase soy agar (BBL Microbiology System, CockeysIron uptake assays. Cultures were grown in M9-glucose medium to a density of 108 CFU/ml. Uptake reactions were initiated by the addition of 100 jig (1 ,uCi) of 59FeC13 (Amersham Corp., Arlington Heights, Ill.) and 1.0 jig of pyochelin in a total of 100 ,ul. One-milliliter samples of the reaction mixtures were removed at 10-min intervals and filtered, and the amount of 59Fe accumulated was determined as previously described (12) in a Compugamma counter (LKB Instruments, Inc., Rockville, Md.).
RESULTS
Production of pyochelin. Forty-three P. cepacia isolates from Toronto, Ontario, and Cleveland, Ohio, were screened for the production of pyochelin. Ethyl acetate extracts of culture supernatants were concentrated and chromatographed on a thin layer of silica gel. Pyochelin was detected by yellow-green fluorescence under UV light and by a red-brown reaction with 0.1 M FeCl3 in 0.1 M HCl. All cultures were assayed in triplicate. Twenty-one strains (49%) produced pyochelin, and 22 strains (51%) did not produce detectable pyochelin. Pyochelin purified from P. cepacia strains had UV and visible absorption spectra identical to those of pyochelin from P. aeruginosa PAO, with peaks at 210, 250, and 310 nm (3) .
The correlation between the production of pyochelin by P. cepacia isolates and the severity of infection in patients is shown in Table 1 . Of the 16 strains with which P. cepacia infections resulted in death, 11 strains produced pyochelin. Conversely, of 16 strains which only caused a mild or moderate infection, 13 did not produce detectable pyochelin. Pyochelin production by these isolates correlated with morbidity and mortality in these patients (chi-square analysis; P < 0.05).
Uptake of ferripyochelin. Since many bacteria can use siderophores from other species and strains to transport iron (7, 9) , the ability of P. cepacia strains to accumulate ferripyochelin was examined. Cultures were grown in minimal medium, in which the production of pyochelin is not detectable (1), to a density of 108 CFU/ml. 59Fe-pyochelin was added to the cultures, and the amount of "9Fe accumulated was determined at 10-min intervals (Fig. 1) . A strain which was pyochelin positive, Pc275c, and two strains which did not produce detectable pyochelin, K30-6 and K37-3, were compared in this assay. All three strains accumulated 59Fe when the reactions were initiated with 59Fe-pyochelin. There were no significant differences in the rate of uptake between the pyochelin-negative strains and the positive strain.
Effect of pyochelin on growth. The effect of pyochelin on the growth rate of P. cepacia isolates was examined in minimal medium supplemented with 100 ,ug of transferrin per ml. The addition of transferrin to the culture medium decreased the rate of growth of P. cepacia isolates by at least 50%. P. cepacia strains were grown for 24 h in minimal medium with the iron chelator ethylenediamine-N,N'-diacetic acid to ensure that the bacteria were iron starved. These cultures were diluted into transferrin medium at an initial density of approximately 105 CFU/ml. The cultures were divided in half, and pyochelin was added to one set of cultures at a final concentration of 10 ,ug/ml. Growth was determined by measuring the A600 over a 48-h period. A representative growth curve in the presence and absence of pyochelin is shown in Fig. 2 . The strain in Fig. 2, K37-3 , did 3 .00 + 0.29 h. The mean generation time in the absence of pyochelin was 3.54 ± 0.26 h. Therefore, the addition of pyochelin to transferrin medium decreased the generation time by 15.2% (P < 0.02; paired t test). DISCUSSION P. cepacia isolates from CF patients were assayed for the production of the siderophore pyochelin. Forty-nine percent of these strains produced pyochelin detectable by this assay system. The incidence of pyochelin production in P. cepacia isolates differs significantly from the incidence in P. aeruginosa isolates. All P. aeruginosa clinical isolates produce pyochelin (3). Therefore, although pyochelin promotes the growth of P. aeruginosa in vitro and in vivo (2) , the production of pyochelin probably does not contribute to the vast differences in virulence among P. aeruginosa strains.
The present study, however, strongly suggests that pyochelin production does correlate with the virulence of P. cepacia strains in respiratory infections of CF patients. Strains producing pyochelin were more frequently isolated from patients with severe infections, whereas 81% of strains causing only mild or moderate infections did not produce detectable pyochelin.
Pyochelin was shown to stimulate the growth of P. cepacia in vitro in the presence of transferrin. This stimulation of growth, as measured by a decrease in the generation time with pyochelin added to the medium, was significant (P < 0.02). Although a decrease of 15% may not appear dramatic enough to account for the difference in virulence in CF patients, the effects of pyochelin on the growth of P. cepacia may be greater in vivo in CF lungs than in broth culture.
The observation that P. cepacia strains which do not produce pyochelin can take up ferripyochelin may be important, since often both P. cepacia and P. aeruginosa are isolated from the same CF patient. Therefore, there may be synergy between these organisms in that the P. cepacia isolates may use pyochelin from P. aeruginosa if they do not produce their own pyochelin. Pyochelins isolated from P, aeruginosa and P. cepacia appear to be identical. No difference was observed in the growth promotion or iron uptake experiments regardless of whether pyochelin was isolated from P. cepacia or P. aeruginosa (data not shown). Studies are currently in progress in my laboratory to determine the potential for synergy between these Pseudomonas species in lung infections.
